Annual Operating Profit
-$45.41 M
-$5.51 M-13.81%
31 December 2023
Summary:
Cardiff Oncology annual operaing income is currently -$45.41 million, with the most recent change of -$5.51 million (-13.81%) on 31 December 2023. During the last 3 years, it has fallen by -$26.33 million (-137.93%). CRDF annual operating profit is now -1425.53% below its all-time high of -$2.98 million, reached on 31 December 2011.CRDF Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$12.60 M
-$56.00 K-0.45%
30 September 2024
Summary:
Cardiff Oncology quarterly operating income is currently -$12.60 million, with the most recent change of -$56.00 thousand (-0.45%) on 30 September 2024. Over the past year, it has dropped by -$1.78 million (-16.46%). CRDF quarterly operating profit is now -668.23% below its all-time high of $2.22 million, reached on 31 December 2018.CRDF Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$46.41 M
-$1.78 M-3.99%
30 September 2024
Summary:
Cardiff Oncology TTM operating income is currently -$46.41 million, with the most recent change of -$1.78 million (-3.99%) on 30 September 2024. Over the past year, it has dropped by -$1.94 million (-4.36%). CRDF TTM operating profit is now -6345.97% below its all-time high of -$720.00 thousand, reached on 31 March 2011.CRDF TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.8% | -16.5% | -4.4% |
| 3 y3 years | -137.9% | -80.1% | -79.7% |
| 5 y5 years | -177.1% | -199.5% | -356.3% |
CRDF Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -137.9% | at low | -80.1% | at low | -79.7% | at low |
| 5 y | 5 years | -177.1% | at low | -207.2% | at low | -356.3% | at low |
| alltime | all time | -1425.5% | at low | -668.2% | at low | -6346.0% | at low |
Cardiff Oncology Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.60 M(+0.4%) | -$46.41 M(+4.0%) |
| June 2024 | - | -$12.54 M(+14.7%) | -$44.63 M(+0.8%) |
| Mar 2024 | - | -$10.93 M(+5.8%) | -$44.29 M(-2.5%) |
| Dec 2023 | -$45.41 M(+13.8%) | -$10.33 M(-4.5%) | -$45.41 M(+2.1%) |
| Sept 2023 | - | -$10.82 M(-11.4%) | -$44.47 M(+4.3%) |
| June 2023 | - | -$12.21 M(+1.3%) | -$42.65 M(+4.3%) |
| Mar 2023 | - | -$12.05 M(+28.3%) | -$40.88 M(+2.5%) |
| Dec 2022 | -$39.90 M(+38.3%) | -$9.39 M(+4.4%) | -$39.90 M(-0.3%) |
| Sept 2022 | - | -$8.99 M(-13.9%) | -$40.04 M(+5.2%) |
| June 2022 | - | -$10.44 M(-5.7%) | -$38.04 M(+10.3%) |
| Mar 2022 | - | -$11.07 M(+16.3%) | -$34.49 M(+19.5%) |
| Dec 2021 | -$28.86 M(+51.2%) | -$9.53 M(+36.1%) | -$28.86 M(+11.7%) |
| Sept 2021 | - | -$7.00 M(+1.6%) | -$25.83 M(+11.4%) |
| June 2021 | - | -$6.89 M(+26.6%) | -$23.19 M(+13.7%) |
| Mar 2021 | - | -$5.44 M(-16.2%) | -$20.40 M(+6.9%) |
| Dec 2020 | -$19.09 M(+14.4%) | -$6.50 M(+48.9%) | -$19.09 M(+13.1%) |
| Sept 2020 | - | -$4.36 M(+6.4%) | -$16.88 M(+0.9%) |
| June 2020 | - | -$4.10 M(-0.5%) | -$16.72 M(-0.7%) |
| Mar 2020 | - | -$4.12 M(-3.9%) | -$16.84 M(+1.0%) |
| Dec 2019 | -$16.68 M(+1.8%) | -$4.29 M(+1.9%) | -$16.68 M(+64.0%) |
| Sept 2019 | - | -$4.21 M(-0.3%) | -$10.17 M(-8.1%) |
| June 2019 | - | -$4.22 M(+6.5%) | -$11.06 M(+0.2%) |
| Mar 2019 | - | -$3.96 M(-278.7%) | -$11.04 M(-5.9%) |
| Dec 2018 | -$16.39 M(-30.0%) | $2.22 M(-143.5%) | -$11.73 M(-31.9%) |
| Sept 2018 | - | -$5.10 M(+21.5%) | -$17.23 M(-4.1%) |
| June 2018 | - | -$4.20 M(-9.9%) | -$17.98 M(-8.6%) |
| Mar 2018 | - | -$4.66 M(+41.9%) | -$19.67 M(-16.0%) |
| Dec 2017 | -$23.42 M | -$3.28 M(-43.9%) | -$23.42 M(-19.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$5.84 M(-0.8%) | -$29.13 M(-12.3%) |
| June 2017 | - | -$5.89 M(-29.9%) | -$33.21 M(-11.0%) |
| Mar 2017 | - | -$8.41 M(-6.5%) | -$37.30 M(-5.2%) |
| Dec 2016 | -$39.36 M(+55.7%) | -$8.99 M(-9.4%) | -$39.36 M(+4.3%) |
| Sept 2016 | - | -$9.92 M(-0.6%) | -$37.75 M(+10.3%) |
| June 2016 | - | -$9.98 M(-4.6%) | -$34.23 M(+10.9%) |
| Mar 2016 | - | -$10.46 M(+41.6%) | -$30.88 M(+22.2%) |
| Dec 2015 | -$25.27 M(+69.1%) | -$7.38 M(+15.2%) | -$25.26 M(+12.9%) |
| Sept 2015 | - | -$6.41 M(-3.2%) | -$22.38 M(+12.4%) |
| June 2015 | - | -$6.62 M(+36.6%) | -$19.91 M(+20.5%) |
| Mar 2015 | - | -$4.85 M(+7.6%) | -$16.53 M(+10.6%) |
| Dec 2014 | -$14.95 M(+39.8%) | -$4.50 M(+14.3%) | -$14.95 M(+12.5%) |
| Sept 2014 | - | -$3.94 M(+21.6%) | -$13.29 M(+6.9%) |
| June 2014 | - | -$3.24 M(-0.6%) | -$12.43 M(+7.5%) |
| Mar 2014 | - | -$3.26 M(+14.4%) | -$11.56 M(+8.1%) |
| Dec 2013 | -$10.69 M(+120.5%) | -$2.85 M(-7.4%) | -$10.69 M(+15.2%) |
| Sept 2013 | - | -$3.08 M(+29.6%) | -$9.28 M(+28.2%) |
| June 2013 | - | -$2.37 M(-0.7%) | -$7.24 M(+18.5%) |
| Mar 2013 | - | -$2.39 M(+66.6%) | -$6.11 M(+26.0%) |
| Dec 2012 | -$4.85 M(+62.9%) | -$1.43 M(+38.1%) | -$4.85 M(+13.0%) |
| Sept 2012 | - | -$1.04 M(-16.6%) | -$4.29 M(+7.7%) |
| June 2012 | - | -$1.25 M(+10.2%) | -$3.99 M(+17.7%) |
| Mar 2012 | - | -$1.13 M(+28.8%) | -$3.39 M(+13.8%) |
| Dec 2011 | -$2.98 M(-44.7%) | -$877.20 K(+19.8%) | -$2.98 M(+41.8%) |
| Sept 2011 | - | -$732.20 K(+13.1%) | -$2.10 M(+53.5%) |
| June 2011 | - | -$647.40 K(-10.1%) | -$1.37 M(+89.9%) |
| Mar 2011 | - | -$720.00 K | -$720.00 K |
| Dec 2010 | -$5.38 M | - | - |
FAQ
- What is Cardiff Oncology annual operaing income?
- What is the all time high annual operating profit for Cardiff Oncology?
- What is Cardiff Oncology annual operating profit year-on-year change?
- What is Cardiff Oncology quarterly operating income?
- What is the all time high quarterly operating profit for Cardiff Oncology?
- What is Cardiff Oncology quarterly operating profit year-on-year change?
- What is Cardiff Oncology TTM operating income?
- What is the all time high TTM operating profit for Cardiff Oncology?
- What is Cardiff Oncology TTM operating profit year-on-year change?
What is Cardiff Oncology annual operaing income?
The current annual operating profit of CRDF is -$45.41 M
What is the all time high annual operating profit for Cardiff Oncology?
Cardiff Oncology all-time high annual operaing income is -$2.98 M
What is Cardiff Oncology annual operating profit year-on-year change?
Over the past year, CRDF annual operaing income has changed by -$5.51 M (-13.81%)
What is Cardiff Oncology quarterly operating income?
The current quarterly operating profit of CRDF is -$12.60 M
What is the all time high quarterly operating profit for Cardiff Oncology?
Cardiff Oncology all-time high quarterly operating income is $2.22 M
What is Cardiff Oncology quarterly operating profit year-on-year change?
Over the past year, CRDF quarterly operating income has changed by -$1.78 M (-16.46%)
What is Cardiff Oncology TTM operating income?
The current TTM operating profit of CRDF is -$46.41 M
What is the all time high TTM operating profit for Cardiff Oncology?
Cardiff Oncology all-time high TTM operating income is -$720.00 K
What is Cardiff Oncology TTM operating profit year-on-year change?
Over the past year, CRDF TTM operating income has changed by -$1.94 M (-4.36%)